Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,032 | 431 | 98.1% |
| Education | $133.47 | 5 | 1.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $1,116 | 91 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $879.14 | 58 | $0 (2022) |
| Novo Nordisk Inc | $871.75 | 52 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $473.81 | 22 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $447.23 | 22 | $0 (2022) |
| Lilly USA, LLC | $426.22 | 28 | $0 (2022) |
| Amgen Inc. | $349.90 | 18 | $0 (2022) |
| Merck Sharp & Dohme LLC | $316.34 | 22 | $0 (2022) |
| Nestle HealthCare Nutrition Inc. | $210.63 | 10 | $0 (2022) |
| Sunovion Pharmaceuticals Inc. | $173.33 | 9 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $1,215 | 59 | AstraZeneca Pharmaceuticals LP ($204.71) |
| 2021 | $1,546 | 84 | PFIZER INC. ($329.88) |
| 2020 | $1,054 | 65 | PFIZER INC. ($277.07) |
| 2019 | $1,431 | 94 | PFIZER INC. ($210.19) |
| 2018 | $886.02 | 62 | Janssen Pharmaceuticals, Inc ($195.34) |
| 2017 | $1,034 | 72 | Novo Nordisk Inc ($177.65) |
All Payment Transactions
436 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/21/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $23.36 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/15/2022 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $12.14 | General |
| Category: INSOMNIA | ||||||
| 12/08/2022 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $19.83 | General |
| Category: ANTIBIOTIC | ||||||
| 12/06/2022 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $22.59 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/29/2022 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $19.98 | General |
| Category: Central Nervous System | ||||||
| 11/29/2022 | Merck Sharp & Dohme LLC | BELSOMRA (Drug), STEGLUJAN, STEGLATRO | Food and Beverage | In-kind items and services | $12.02 | General |
| Category: NEUROSCIENCE | ||||||
| 11/22/2022 | Abbott Laboratories | FREESTYLE LIBRE (Device) | Food and Beverage | In-kind items and services | $19.92 | General |
| Category: Diabetes Care | ||||||
| 11/21/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $20.82 | General |
| Category: Cardio-renal | ||||||
| 11/17/2022 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $22.45 | General |
| Category: ANTIBIOTIC | ||||||
| 11/15/2022 | Nestle HealthCare Nutrition Inc. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $21.18 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 11/14/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.08 | General |
| Category: Diabetes | ||||||
| 11/10/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $11.40 | General |
| Category: Diabetes | ||||||
| 11/08/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $29.59 | General |
| Category: PRIMARY CARE | ||||||
| 11/07/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $24.76 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/31/2022 | Lilly USA, LLC | EMGALITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $12.40 | General |
| Category: Neuroscience | ||||||
| 10/27/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $21.54 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/17/2022 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $14.37 | General |
| Category: Diabetes | ||||||
| 09/12/2022 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $21.96 | General |
| Category: ANTIBIOTIC | ||||||
| 09/09/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | Cash or cash equivalent | $28.88 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/23/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $21.08 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/18/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $20.07 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/12/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $20.87 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/03/2022 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $12.22 | General |
| Category: Respiratory | ||||||
| 08/02/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $20.25 | General |
| Category: Cardio-renal | ||||||
| 07/29/2022 | Lilly USA, LLC | BAQSIMI (Drug), TRULICITY | Food and Beverage | In-kind items and services | $21.38 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 1,203 | 1,697 | $328,097 | $83,759 |
| 2022 | 31 | 3,037 | 4,210 | $490,496 | $123,667 |
| 2021 | 28 | 2,879 | 4,089 | $470,700 | $123,636 |
| 2020 | 30 | 2,643 | 3,984 | $441,634 | $96,950 |
All Medicare Procedures & Services
108 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 196 | 477 | $119,154 | $26,958 | 22.6% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 154 | 272 | $78,880 | $21,459 | 27.2% |
| 99305 | Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | Facility | 2023 | 170 | 178 | $73,336 | $18,692 | 25.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 76 | 80 | $20,000 | $5,585 | 27.9% |
| 87502 | Detection test by nucleic acid for multiple types influenza virus | Office | 2023 | 28 | 28 | $8,400 | $2,629 | 31.3% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2023 | 39 | 39 | $7,800 | $1,961 | 25.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 124 | 146 | $2,482 | $1,226 | 49.4% |
| 87634 | Detection test by nucleic acid for respiratory syncytial virus, amplified probe technique | Office | 2023 | 15 | 15 | $3,225 | $1,032 | 32.0% |
| 99315 | Nursing facility discharge day management, 30 minutes or less | Facility | 2023 | 13 | 13 | $3,029 | $854.62 | 28.2% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 68 | 71 | $2,556 | $734.85 | 28.8% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 89 | 93 | $2,418 | $707.73 | 29.3% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 25 | 27 | $1,555 | $444.42 | 28.6% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 27 | 27 | $1,350 | $437.40 | 32.4% |
| 81003 | Automated urinalysis test | Office | 2023 | 92 | 139 | $1,112 | $305.80 | 27.5% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 19 | 20 | $1,000 | $262.40 | 26.2% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 21 | 23 | $920.00 | $218.96 | 23.8% |
| 84550 | Uric acid level, blood | Office | 2023 | 24 | 25 | $400.00 | $110.75 | 27.7% |
| 83690 | Lipase (fat enzyme) level | Office | 2023 | 12 | 12 | $276.00 | $81.00 | 29.3% |
| 82248 | Bilirubin level, direct | Office | 2023 | 11 | 12 | $204.00 | $59.04 | 28.9% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Office | 2022 | 235 | 662 | $165,500 | $33,344 | 20.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 238 | 238 | $95,200 | $32,383 | 34.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 247 | 367 | $91,750 | $19,966 | 21.8% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2022 | 304 | 457 | $22,850 | $6,045 | 26.5% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 57 | 95 | $12,540 | $3,754 | 29.9% |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | Office | 2022 | 38 | 41 | $9,225 | $3,050 | 33.1% |
About Dr. Christopher Lebo, D.O
Dr. Christopher Lebo, D.O is a Family Medicine healthcare provider based in Somerset, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/14/2005. The National Provider Identifier (NPI) number assigned to this provider is 1477558823.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Lebo, D.O has received a total of $7,165 in payments from pharmaceutical and medical device companies, with $1,215 received in 2022. These payments were reported across 436 transactions from 37 companies. The most common payment nature is "Food and Beverage" ($7,032).
As a Medicare-enrolled provider, Lebo has provided services to 9,762 Medicare beneficiaries, totaling 13,980 services with total Medicare billing of $428,013. Data is available for 4 years (2020–2023), covering 108 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Somerset, MA
- Active Since 06/14/2005
- Last Updated 04/02/2008
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1477558823
Products in Payments
- XARELTO (Drug) $612.67
- CHANTIX (Drug) $596.96
- Ozempic (Drug) $506.37
- ELIQUIS (Drug) $304.66
- INVOKANA (Drug) $266.47
- JANUVIA (Drug) $219.66
- Aimovig (Biological) $211.54
- ZENPEP (Drug) $210.63
- FARXIGA (Drug) $199.42
- Victoza (Drug) $186.52
- TRADJENTA (Drug) $178.64
- TRULICITY (Drug) $171.14
- ENTRESTO (Drug) $149.99
- JARDIANCE (Drug) $138.67
- NUZYRA (Drug) $138.02
- Kerendia (Drug) $137.42
- TROKENDI XR (Drug) $133.37
- XIFAXAN (Drug) $127.41
- BAQSIMI (Drug) $125.76
- PRALUENT (Biological) $112.61
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Somerset
Dr. Robert Drake, Md, MD
Family Medicine — Payments: $14,200
Jeffrey Vanmeter, M.d, M.D
Family Medicine — Payments: $14,143
Dr. Marlo Marcheleovich, D.o, D.O
Family Medicine — Payments: $9,217
Lana New
Family Medicine — Payments: $8,316
Barbara Etheridge, M.d, M.D
Family Medicine — Payments: $4,585
John Brennan, Md, MD
Family Medicine — Payments: $4,051